Corcept Therapeutics (CORT) Amortizatization of Intangibles (2012 - 2017)
Corcept Therapeutics (CORT) posted Amortizatization of Intangibles of $44000.0 for Q4 2017, up 18.92% sequentially from $37000.0 in Q3 2017, and down 88.01% YoY from $367000.0 in Q4 2016.
Corcept Therapeutics (CORT) Amortizatization of Intangibles (2012 - 2017) Analysis & Trends
Corcept Therapeutics has reported Amortizatization of Intangibles for 6 years, with the latest figure at $44000.0 in Q4 2017.
- Quarterly Amortizatization of Intangibles fell 88.01% year-over-year to $44000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $500000.0 (down 74.08% YoY) and the FY2025 annual result came in at $5.1 million, down 53.35% from the prior year.
- Amortizatization of Intangibles rose to $44000.0 in Q4 2017 per CORT's latest filing, from $37000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $5.0 million in Q3 2013 and troughed at $37000.0 in Q3 2017.
- A 5-year average of $946300.0 and a median of $717500.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2013 and 2017: Amortizatization of Intangibles decreased 3.17% in 2013, then sank 91.87% in 2017.
- Over 5 years, Amortizatization of Intangibles stood at $1.1 million in 2013, then retreated by 24.86% to $804000.0 in 2014, then retreated by 18.91% to $652000.0 in 2015, then plunged by 43.71% to $367000.0 in 2016, then slumped by 88.01% to $44000.0 in 2017.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $44000.0, $37000.0, and $149000.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 44,000.00 |
| Dec 31, 2017 | 44,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 149,000.00 |
| Jun 30, 2017 | 149,000.00 |
| Mar 31, 2017 | 270,000.00 |
| Mar 31, 2017 | 270,000.00 |
| Dec 31, 2016 | 367,000.00 |
| Dec 31, 2016 | 367,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Jun 30, 2016 | 523,000.00 |
| Jun 30, 2016 | 523,000.00 |
| Mar 31, 2016 | 584,000.00 |
| Mar 31, 2016 | 584,000.00 |
| Dec 31, 2015 | 652,000.00 |
| Dec 31, 2015 | 652,000.00 |
| Sep 30, 2015 | 698,000.00 |
| Sep 30, 2015 | 698,000.00 |